SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Laurus Labs trades higher as its arm incorporates wholly-owned subsidiary

12 Jan 2021 Evaluate

Laurus Labs is currently trading at Rs. 351.00, up by 0.85 points or 0.24 % from its previous closing of Rs. 350.15 on the BSE.

The scrip opened at Rs. 349.95 and has touched a high and low of Rs. 351.65 and Rs. 348.00 respectively. So far 1548 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 365.65 on 21-Dec-2020 and a 52 week low of Rs. 61.90 on 24-Mar-2020.

Last one week high and low of the scrip stood at Rs. 365.00 and Rs. 347.00 respectively. The current market cap of the company is Rs. 18789.13 crore.

The promoters holding in the company stood at 32.12 % while Institutions and Non-Institutions held 27.08 % and 40.79 % respectively.

Laurus Labs’ wholly-owned Subsidiary -- Laurus Synthesis has incorporated a wholly-owned subsidiary under name and style Laurus Ingredients. The said incorporation is for undertaking ingredients business and also for setting up Greenfield projects for new synthesis business. The new entity Laurus Ingredients shall be a step-down subsidiary for Laurus Labs.

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.

Laurus Labs Share Price

1569.25 0.95 (0.06%)
24-Jul-2026 10:43 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1949.90
Dr. Reddys Labs. 1142.95
Cipla 1420.30
Lupin 2358.95
Zydus Lifesciences 1112.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: